5:00 PM Panel: Discussing the Evolving Role of Biomarkers for Therapeutic Differentiation in a Crowded Landscape
Time: 5:00 pm
day: Conference Day 1
Details:
- Exploring the increasing need for biomarkers that can meaningfully differentiate the clinical impact of emerging renal therapies for rare kidney diseases
- Discussing the repurposing of established biomarkers in new contexts to reveal subtle and clinically relevant differences between new treatments
- Addressing opportunities and challenges in utilizing novel biomarkers in rare kidney disease trials to demonstrate clinical relevance
- Understanding the validation journey needed to gain acceptance within the community and regulatory agencies
